GSTT1 Copy Number Gain and ZNF Overexpression Are Predictors of Poor Response to Imatinib in Gastrointestinal Stromal Tumors

Oncogenic mutations in gastrointestinal stromal tumors (GISTs) predict prognosis and therapeutic responses to imatinib. In wild-type GISTs, the tumor-initiating events are still unknown, and wild-type GISTs are resistant to imatinib therapy. We performed an association study between copy number alte...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eui Jin, Kang, Guhyun, Kang, Shin Woo, Jang, Kee-Taek, Lee, Jeeyun, Park, Joon Oh, Park, Cheol Keun, Sohn, Tae Sung, Kim, Sung, Kim, Kyoung-Mee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790698/
https://www.ncbi.nlm.nih.gov/pubmed/24124608
http://dx.doi.org/10.1371/journal.pone.0077219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790698/
https://www.ncbi.nlm.nih.gov/pubmed/24124608
http://dx.doi.org/10.1371/journal.pone.0077219

Ejemplares similares